Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice

Highlights • Lineage 2 WNV causes encephalitis in humans and horses in South Africa and Europe. • Commercial vaccines’ efficacy is evaluated against WNV lineage 1 strains only. • Duvaxyn WNV vaccine protected completely against challenge with lineage 2 in mice. • Significant cross neutralising antib...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2013-08, Vol.31 (37), p.3856-3862
Hauptverfasser: Venter, Marietjie, van Vuren, Petrus Janse, Mentoor, Juliet, Paweska, Janusz, Williams, June
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Lineage 2 WNV causes encephalitis in humans and horses in South Africa and Europe. • Commercial vaccines’ efficacy is evaluated against WNV lineage 1 strains only. • Duvaxyn WNV vaccine protected completely against challenge with lineage 2 in mice. • Significant cross neutralising antibodies was detected in vaccinated mice. • This vaccine could protect against lineage 2 WNV neurological disease in horses.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2013.06.059